Jin Medical International Ltd. — Form 6-K Summary
Business Context and Reporting Period
This Form 6-K covers March 2024 and was filed by Jin Medical International Ltd., a foreign private issuer headquartered in Changzhou, Jiangsu Province, China. The company files annual reports on Form 20-F.
Key Financial Metrics
The filing does not provide revenue, profit, cash flow, margins, debt, liquidity, or other financial performance metrics.
Material Changes
On February 26, 2024, DNTW Toronto LLP resigned as the company’s independent registered public accounting firm, effective immediately. On March 1, 2024, the Audit Committee approved the engagement of Audit Alliance LLP as the new independent registered public accounting firm.
The filing states that, from September 23, 2023 through February 28, 2024, there were no disagreements with DNTW regarding accounting principles or practices, financial statement disclosure, or audit scope or procedures. It also reports no reportable events requiring disclosure under Item 16F(a)(1)(iv) of Form 20-F.
Guidance, Outlook, Risks, and Unusual Items
No financial guidance, business outlook, contingencies, or operating risks are disclosed. The auditor transition is the principal unusual item reported.
Investor Verification Items
- Verify the appointment and subsequent work of Audit Alliance LLP as the company’s independent registered public accounting firm.
- Review future filings for any developments concerning the audit of the year ended September 30, 2023.
- Confirm whether future filings disclose any disagreements, reportable events, audit qualifications, or material weaknesses.
- Obtain the company’s Form 20-F and other financial filings for financial performance, liquidity, debt, and risk information not included in this Form 6-K.